What is the best management for hydronephrosis in a patient with a history of stage four prostate cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hydronephrosis in Advanced Prostate Cancer

The best management for this patient's left hydronephrosis is retrograde ureteral stenting or percutaneous nephrostomy (PCN) placement to relieve the obstruction. 1

Assessment of the Clinical Situation

This 78-year-old man presents with:

  • Stage IV prostate adenocarcinoma treated with bilateral orchiectomy 3 years ago
  • Marked left hydronephrosis on ultrasound with normal right kidney
  • Currently asymptomatic
  • Serum creatinine of 1.4 mg/dL (mild renal impairment)
  • PSA level of 31 mg/mL (indicating disease progression)

Management Algorithm

Step 1: Determine the Urgency of Intervention

  • Despite being asymptomatic, intervention is necessary because:
    • Elevated creatinine indicates renal function impairment
    • High PSA suggests active disease progression
    • Unilateral hydronephrosis with normal contralateral kidney suggests ureteral obstruction from tumor

Step 2: Select the Appropriate Intervention

Two equivalent primary options exist 1:

  1. Retrograde Ureteral Stenting:

    • First-line therapy for management of ureteral obstruction caused by malignancy
    • Performed via cystoscopy
    • Less invasive than PCN
    • May have lower technical success rate with extrinsic compression

  2. Percutaneous Nephrostomy (PCN):

    • Higher technical success rate in relieving obstruction compared to retrograde stenting, especially with extrinsic compression
    • Provides immediate decompression
    • Can be converted to internal-external nephroureteral stent if needed

Step 3: Follow-up and Additional Management

  • Monitor renal function with serial creatinine measurements
  • Consider systemic therapy for disease progression (PSA 31 mg/mL despite orchiectomy indicates castration-resistant disease)
  • Periodic imaging to assess response and stent function

Evidence-Based Considerations

The ACR Appropriateness Criteria for Radiologic Management of Urinary Tract Obstruction specifically addresses malignant obstruction, noting that retrograde ureteral stenting or PCN are usually appropriate for patients with advanced malignancy and hydronephrosis 1.

For patients with advanced cervical carcinoma (which can be extrapolated to advanced prostate cancer with similar obstructive patterns), both retrograde ureteral stenting and PCN are considered equivalent first-line interventions 1.

Important Caveats

  • Technical success rates: PCN could have a higher technical success rate in relieving obstruction compared with retrograde double-J ureteral stenting, especially in cases due to extrinsic compression 1

  • Stent maintenance: Ureteral stents typically require exchange every 3-6 months to prevent encrustation and obstruction

  • Prognostic implications: Hydronephrosis in prostate cancer has been shown to have independent prognostic value for disease progression after hormonal treatment and correlates with shorter survival 2

  • Quality of life considerations: Internal stents generally provide better quality of life than external nephrostomy tubes, but may not be technically feasible in all cases

  • Complication risks: Both procedures carry risks of infection, bleeding, and technical failure. PCN has additional risks of pleural complications if a high approach is used 3

In this patient with asymptomatic hydronephrosis but elevated creatinine and PSA, prompt intervention is necessary to preserve renal function and prevent further complications, even though he is currently not experiencing symptoms directly related to the hydronephrosis.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the best management option for hydronephrosis (fluid accumulation in the kidney) in a patient with stage 4 prostate cancer (cancer of the prostate gland) and impaired renal function (elevated serum creatinine level)?
What is the preferred initial treatment for hydronephrosis (obstruction of urine flow) in a patient with stage 4 prostate cancer, percutaneous nephrostomy (PCN) or ureteral stent?
What's the best approach for managing asymptomatic hydronephrosis in a patient with a history of stage four prostate cancer?
What is the best management for a 78-year-old man with stage IV (four) adenocarcinoma of the prostate, presenting with left hydronephrosis (kidney swelling due to obstruction) and impaired renal function (elevated serum creatinine), after previous treatment with bilateral orchiectomy (surgical removal of testes)?
What is the management plan for a 71-year-old man, 1 week post-prostatectomy, presenting with generalized body edema, abdominal distention, bilateral lower limb edema, mild difficulty breathing, impaired renal function (elevated urea and creatinine), abdominal abscess, bladder stasis, and right lung pleural effusion?
Can an abdominal ultrasound (US) detect a gastric ulcer?
How to confirm lower extremity deep vein thrombosis (DVT) when ultrasound is inconclusive?
Can elderly patients receive a steroid injection?
What are the benefits of steroid use in a patient with mild nasal congestion and chills?
What are the primary treatment recommendations for COVID-19?
What are the next steps for a 1 cm coarse calcified mass in the testicle identified on ultrasound?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question